10X GENOMICS INC CLASS A (TXG)
Sector: Health Care
Sector: Health Care
10X GENOMICS INC CLASS A - Executive Compensation
President and Chief Scientific Officer
Executive Compensation
Benjamin J. Hindson is a distinguished figure in the biotechnology industry, currently serving as the President and Chief Scientific Officer at 10x Genomics, Inc. Class A. With a robust background in molecular biology and genetics, Hindson has been instrumental in driving the company's mission to advance scientific discovery through innovative genomic solutions. His leadership has been pivotal in positioning 10x Genomics at the forefront of the genomics revolution, where the company specializes in developing products for analyzing biological systems at a resolution and scale that was previously unattainable. Prior to his role at 10x Genomics, Hindson amassed a wealth of experience in the biotech sector, contributing to significant advancements in the field. He holds a Ph.D. in Biochemistry from the University of California, Davis, and has authored numerous scientific publications that have furthered the understanding of genomic technologies. At 10x Genomics, Hindson oversees the scientific strategy and spearheads the development of cutting-edge technologies that empower researchers to explore the complexities of biology in unprecedented ways. His visionary approach and dedication to scientific excellence have not only propelled the company's growth but have also earned him recognition as a leader in the genomics community. In his capacity as President and Chief Scientific Officer, Hindson plays a crucial role in shaping the future of 10x Genomics. He is responsible for guiding the company's research and development efforts, ensuring that new products meet the highest standards of innovation and utility. Under his leadership, 10x Genomics has successfully launched several groundbreaking platforms, including the Chromium and Visium systems, which have revolutionized single-cell and spatial genomics research. Hindson's commitment to advancing scientific knowledge and his ability to translate complex research into practical applications continue to drive the company's success and impact on the global scientific community.